These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 5431926)

  • 1. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease.
    Rosenthal A; Nathan DG; Marty AT; Button LN; Miettinen OS; Nadas AS
    Circulation; 1970 Aug; 42(2):297-308. PubMed ID: 5431926
    [No Abstract]   [Full Text] [Related]  

  • 2. Late circulatory adjustments to acute normovolemic polycythemia.
    Weisse AB; Regan TJ; Nadimi M; Hellems HK
    Am J Physiol; 1966 Dec; 211(6):1413-8. PubMed ID: 5956558
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.
    Rosove MH; Perloff JK; Hocking WG; Child JS; Canobbio MM; Skorton DJ
    Lancet; 1986 Aug; 2(8502):313-5. PubMed ID: 2874330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia.
    Horigome H; Hiramatsu Y; Shigeta O; Nagasawa T; Matsui A
    J Am Coll Cardiol; 2002 Mar; 39(6):1072-7. PubMed ID: 11897453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of normovolemic polycythemia and hypoxia on hemodynamics in the dog.
    McGrath RL; Weil JV
    Circ Res; 1978 Nov; 43(5):793-8. PubMed ID: 30544
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease.
    Oldershaw PJ; Sutton MG
    Br Heart J; 1980 Nov; 44(5):584-8. PubMed ID: 7437201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic response to normovolemic polycythemia at rest and during exercise in dogs.
    Lindenfeld J; Weil JV; Travis VL; Horwitz LD
    Circ Res; 1985 Jun; 56(6):793-800. PubMed ID: 4006091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematologic Derangements among Children with Unoperated Cyanotic Congenital Heart Disease in Ethiopia.
    Alemseged S; Tefera E
    Ethiop J Health Sci; 2023 Nov; 33(6):955-962. PubMed ID: 38784485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The circulatory effects of hematocrit variations in normovolemic newborn lambs.
    Fouron JC; Hébert F
    J Pediatr; 1973 Jun; 82(6):995-1003. PubMed ID: 4702920
    [No Abstract]   [Full Text] [Related]  

  • 10. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease.
    Hopkins WE; Hall C
    Circulation; 1997 Oct; 96(7):2215-20. PubMed ID: 9337192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet adhesiveness in cyanotic cogenital heart disease.
    Goldschmidt B; Kun E
    Acta Paediatr Acad Sci Hung; 1973; 14(2):99-103. PubMed ID: 4763565
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical update: cyanotic adult congenital heart disease.
    Spence MS; Balaratnam MS; Gatzoulis MA
    Lancet; 2007 Nov; 370(9598):1530-2. PubMed ID: 17980725
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin in cyanotic heart disease.
    Gidding SS; Stockman JA
    Am Heart J; 1988 Jul; 116(1 Pt 1):128-32. PubMed ID: 3394615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic responses to acute hematocrit and blood volume alterations in rats.
    Wolfe RR; Horvath SM
    Eur J Appl Physiol Occup Physiol; 1976 Jun; 35(2):159-66. PubMed ID: 954733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal rheology in cyanotic congenital heart disease--a factor in non-immune nephropathy.
    Dittrich S; Kurschat K; Lange PE
    Scand J Urol Nephrol; 2001 Oct; 35(5):411-5. PubMed ID: 11771869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment in platelet aggregation in congenital heart disease.
    Mauer HM; McCue CM; Caul J; Still WJ
    Blood; 1972 Aug; 40(2):207-16. PubMed ID: 5044591
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulation in cyanotic congenital heart disease.
    Wedemeyer AL; Edson JR; Krivit W
    Am J Dis Child; 1972 Nov; 124(5):656-60. PubMed ID: 5085479
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease.
    Cordina RL; Celermajer DS
    Cardiol Young; 2010 Jun; 20(3):242-53. PubMed ID: 20416139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
    Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
    Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease.
    DeFilippis AP; Law K; Curtin S; Eckman JR
    Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.